Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients

Expert Review of Clinical Immunology

Volumn 10, Issue 10, 2014, Pages 1405-1417

  Aghamohammadi, Asghar ^a   Abolhassani, Hassan ^a,b   Latif, AmirHossein ^a   Tabassomi, Firouzeh ^a   Shokuhfar, Tahaamin ^a   Torabi Sagvand, Babak ^a   Shahinpour, Shervin ^a   Mirminachi, Babak ^a   Parvaneh, Nima ^a   Movahedi, Masoud ^c   Gharagozlou, Mohammad ^c   Sherkat, Roya ^d   Amin, Reza ^e   Aleyasin, Soheila ^e   Faridhosseini, Reza ^f   Jabbari Azad, Farahzad ^g   Cheraghi, Taher ^h   Eslamian, Mohamad Hosein ^a,c   Khalili, Abbas ^a,c   Kalantari, Najmoddin ⁱ   Shafiei, Alireza ^j   Dabbaghzade, Abbas ^a,c   Khayatzadeh, Alireza ^a,c   Ebrahimi, Mohsen ^a,c   Razavinejad, Davood ^a   Bazregari, Saeid ^a,c   Ebrahimi, Mehran ^a,c   Ghaffari, Javad ^k   Bemanian, Mohammad Hassan ^l   Behniafard, Nasrin ^a,j   Kashef, Sara ^m   Mohammadzadeh, Iraj ⁿ   Hammarström, Lennart ^b   Rezaei, Nima ^a   more..

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^k MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^l YAZD UNIVERSITY   (Iran)

^m SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁿ BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

more..

Author keywords

clinical manifestation; common variable immunodeficiency; epidemiology; laboratory characteristic; retrospective cohort; treatment

Indexed keywords

CD4 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN;

AID GENE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONSANGUINEOUS MARRIAGE; DISEASE PREDISPOSITION; EVALUATION STUDY; GENE; HLA GENE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IRAN; MEMORY CELL; PHENOTYPE; PROGNOSIS; RECURRENT INFECTION; REVIEW; SURVIVAL RATE; ADOLESCENT; ADULT; CHILD; FEMALE; GENETICS; IMMUNOLOGY; MALE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; IRAN; MALE; YOUNG ADULT;

EID: 84907273269     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2014.958469     Document Type: Review

References (130)

1. Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol 2010;125(2 Suppl 2):S182-94
2. Notarangelo LD, Fischer A, Geha RS, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009;124(6):1161-78
3. Aghamohammadi A, Farhoudi A, Moin M, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005;12(7):825-32
4. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999;92(1): 34-48
5. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987;7(4):294-9
6. Ko J, Radigan L, Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 2005; 116(1):37-41
7. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010;116(1):7-15
8. Stiehm E, Ochs H, Winkelstein J. Immunologic disorders in infants and children. Elsevier; Philadelphia, PA: 2004
9. Jolles S. The variable in common variable immunodeficiency: A disease of complex phenotypes. J Allergy Clin Immunol 2013; 1(6):545-56; quiz 557
10. Luzi G, Businco L, Aiuti F. Primary immunodeficiency syndromes in Italy: A report of the national register in children and adults. J Clin Immunol 1983;3(4): 316-20
11. Notarangelo L, Casanova JL, Conley ME, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 2006;117(4): 883-96
12. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: Division into distinct clinical phenotypes. Blood 2008;112(2):277-86
13. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010;116(1):7-15
14. Nourijelyani K, Aghamohammadi A, Salehi Sadaghiani M, et al. Physicians awareness on primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol 2012;11(1):57-64
15. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Q J Med 1993;86(1):31-42
16. Buehring I, Friedrich B, Schaaf J, et al. Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. Clin Exp Immunol 1997;109(3):468-72
17. Kainulainen L, Varpula M, Liippo K, et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999;104(5):1031-6
18. Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep 2004;6(5): 377-83
19. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002;109(6):1001-4
20. Aghamohammadi A, Parvaneh N, Rezaei N. Common variable immunodeficiency: A heterogeneous group needs further subclassification. Expert Rev Clin Immunol 2009;5(6):629-31
21. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93(3):190-7
22. ESID. Available from: Http://esid.org/ Working-Parties/Registry/Documentingcenters/ Iran-Iranian-Primary-Immunodeficiency-Registry-IPIDR.)
23. Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. Primary immunodeficiency disorders in Iran: Update and new insights from the third report of the national registry. J Clin Immunol 2014; 34(4):478-90
24. Aghamohammadi A, Allahverdi A, Abolhassani H, et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010; 15(2):289-95
25. Aghamohammadi A, Abolhassani H, Moazzami K, et al. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol 2010;20(5):372-9
26. Abolhassani H, Aghamohammadi A, Imanzadeh A, et al. Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol 2012;22(2): 133-4
27. Aghamohammadi A, Abolhassani H, Hirbod-Mobarakeh A, et al. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis. Viral Immunol 2012;25(2):161-5
28. Aghamohammadi A, Shafiei A, Abolhassani H, et al. Renal amyloidosis in common variable immunodeficiency. Nefrologia 2010;30(4):474-6
29. Aghamohammadi A, Abolhassani H, Rezaei N, et al. Cutaneous granulomas in common variable immunodeficiency: Case report and review of literature. Acta Dermatovenerol Croat 2010;18(2):107-13
30. Ramyar A, Aghamohammadi A, Moazzami K, et al. Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol 2008;7(3):169-75
31. Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007;52(11):2977-83
32. Aghamohammadi A, Rezaei N, Gharagozlou M, et al. Hodgkin lymphoma in two siblings with common variable immunodeficiency. Pediatr Hematol Oncol 2007;24(5):337-42
33. Aghamohammadi A, Parvaneh N, Tirgari F, et al. Lymphoma of mucosa-Associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 2006; 47(2):343-6
34. Ebrahimi Daryani N, Aghamohammadi A, Mousavi Mirkala MR, et al. Gastrointestinal complications in two patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol 2004;3(3):149-52
35. Mohammadinejad P, Aghamohammadi A, Abolhassani H, et al. Pediatric patients with common variable immunodeficiency: Long-Term follow-up. J Investig Allergol Clin Immunol 2012;22(3):208-14
36. Salehi Sadaghiani M, Aghamohammadi A, Ashrafi MR, et al. Autism in a child with common variable immunodeficiency. Iran J Allergy Asthma Immunol 2013;12(3):287-9
37. Aghamohammadi A, Tavassoli M, Abolhassani H. Infectious and non-infectious complications among undiagnosed patients with common variable immunodeficiency. Iran J Pediatr 2009; 19(4):367-75
38. Rezaei N, Wing JB, Aghamohammadi A, et al. B-cell-T-cell activation and interaction in common variable immunodeficiency. Hum Immunol 2010;71(4):355-62
39. Salehzadeh M, Aghamohammadi A, Rezaei N. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy. J Microbiol Immunol Infect 2010;43(1): 11-17
40. Rezaei N, Aghamohammadi A, Nourizadeh M, et al. Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol 2010;20(3):244-51
41. Abolhassani H, Sagvand BT, Shokuhfar T, et al. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol 2013;9(6):561-74; quiz 575
42. Pourpak Z, Aghamohammadi A, Sedighipour L, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 2006;39(2): 114-20
43. Abolhassani H, Sadaghiani MS, Aghamohammadi A, et al. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: Systematic review and meta analysis. J Clin Immunol 2012;32(6): 1180-92
44. Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev Clin Immunol 2011;7(3):301-16
45. Saroukhani S, Aghamohammadi A, Mahmoudi-Gharaei J, et al. Behavior abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies. Hum Psychopharmacol 2010;25(5):419-22
46. Abolhassani H, Aghamohammadi A, Abolhassani F, et al. Health policy for common variable immunodeficiency: Burden of the disease. J Investig Allergol Clin Immunol 2011;21(6):454-8
47. Aghamohammadi A, Montazeri A, Abolhassani H, et al. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol 2011;10(1):47-51
48. Aghamohammadi A, Pouladi N, Parvaneh N, et al. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr 2007;53(1):32-8
49. Amanzadeh A, Amirzargar AA, Mohseni N, et al. Association of HLA-DRB1, DQA1 and DQB1 Alleles and Haplotypes with Common Variable Immunodeficiency in Iranian Patients. Avicenna J Med Biotechnol 2012;4(2):103-12
50. Rezaei N, Siadat SD, Aghamohammadi A, et al. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin Vaccine Immunol 2010;17(4):524-8
51. Rezaei N, Aghamohammadi A, Siadat SD, et al. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol 2008;15(4):607-11
52. Rezaei N, Aghamohammadi A, Read RC. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease. Iran J Allergy Asthma Immunol 2008;7(4):231-4
53. Aghamohammadi A, Sedighipour L, Saeed SE, et al. Alterations in humoral immunity in relatives of patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2008; 18(4):266-71
54. Mahmoudi M, Hedayat M, Aghamohammadi A, Rezaei N. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2013; 23(2):120-4
55. Rezaei N, Haji-Molla-Hoseini M, Aghamohammadi A, et al. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol 2008; 28(1):78-84
56. Aghamohammadi A, Moin M, Kouhi A, et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 2008; 213(5):447-54
57. Rezaei N, Aghamohammadi A, Kardar GA, et al. T-helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2008;18(6):449-53
58. Ravanbakhsh M, Sarafnejad A, Aghamohammadi A, et al. CD40 ligand expression on stimulated T-helper lymphocytes in patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol 2007;6(3):129-35
59. Nourizadeh M, Aghamohammadi A, Moazzeni SM, et al. Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm Res 2007;56(12):527-32
60. Aghamohammadi A, Foroughi F, Rezaei N, et al. Mannose-binding lectin polymorphisms in common variable immunodeficiency. Clin Exp Med 2009; 9(4):285-90
61. Farhadi E, Nemati S, Amirzargar AA, et al. AICDA single nucleotide polymorphism in common variable immunodeficiency and selective IgA deficiency. Allergol Immunopathol (Madr) 2013. [Epub ahead of print]
62. Rezaei N, Aghamohammadi A, Mahmoudi M, et al. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology 2010; 215(1):81-7
63. Rezaei N, Amirzargar AA, Shakiba Y, et al. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009;155(1):21-7
64. Rezaei N, Aghamohammadi A, Shakiba Y, et al. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol 2009;150(1):1-7
65. Aghamohammadi A, Kanegane H, Moein M, et al. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. Int J Hematol 2003; 78(1):45-7
66. +regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol 2013;281(2):129-33
67. Arandi N, Mirshafiey A, Abolhassani H, et al. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency. Scand J Immunol 2013;77(5):405-12
68. +T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol 2012;22(3):160-7
69. Salek Farrokhi A, Aghamohammadi A, Pourhamdi S, et al. Evaluation of class switch recombination in B lymphocytes of patients with common variable immunodeficiency. J Immunol Methods 2013;394(1-2):94-9
70. Vodjgani M, Aghamohammadi A, Samadi M, et al. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol 2007;17(5):321-8
71. Aghamohammadi A, Farhoudi A, Nikzad M , et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann Allergy Asthma Immunol 2004;92(1):60-4
72. Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 2006;26(6):519-32
73. Farhoudi A, Aghamohammadi A, Moin M, et al. Distribution of primary immunodeficiency disorders diagnosed in the Children's Medical Center in Iran. J Investig Allergol Clin Immunol 2005;15(3): 177-82
74. Shabestari MS, Maljaei SH, Baradaran R, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol 2007;27(5):510-16
75. Lucas M, Lee M, Lortan J, et al. Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010;125(6):1354-60
76. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119(7):1650-7
77. Rivoisy C, Gerard L, Boutboul D, et al. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol 2012; 32(1):98-105
78. Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: Defining subgroups in common variable immunodeficiency. Blood 2008;111(1):77-85
79. Baris S, Ercan H, Cagan HH, et al. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011;21(7):514-21
80. Park MA, Li JT, Hagan JB, et al. Common variable immunodeficiency: A new look at an old disease. Lancet 2008;372(9637): 489-502
81. Maarschalk-Ellerbroek LJ, Hoepelman AI, van Montfrans JM, Ellerbroek PM. The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol 2012;32(5):907-21
82. Gathmann B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014;134(1):116-26
83. Llobet MP, Soler-Palacin P, Detkova D, et al. Common variable immunodeficiency: 20-yr experience at a single centre. Pediatr Allergy Immunol 2009;20(2):113-18
84. Ardeniz O, Basoglu OK, Gunsar F, et al. Clinical and immunological analysis of 23 adult patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2010;20(3):222-36
85. Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008;46(10):1547-54
86. Rezaei N, Mohammadinejad P, Aghamohammadi A. The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment. Ann N Y Acad Sci 2011;1238:24-32
87. de Vries E. European Society for Immunodeficiencies m. Patient-centered screening for primary immunodeficiency. a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol 2012;167(1):108-19
88. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145(6): 709-27
89. Kardar GA, Shams SH, Pourpak Z, Moin M. Normal value of immunoglobulins IgA, IgG, and IgM in Iranian healthy adults, measured by nephelometry. J Immunoassay Immunochem 2003;24(4):359-67
90. Hatagima A, Cabello PH, Krieger H. Causal analysis of the variability of IgA, IgG, and IgM immunoglobulin levels. Hum Biol 1999;71(2):219-29
91. Kacprazak-Bergman I. Sexual dimorphism of heritability of immunoglobulin levels. Ann Hum Biol 1994;21(6):563-9
92. Olerup O, Smith CI, Bjorkander J, Hammarstrom L. Shared HLA class II-Associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci USA 1992;89(22):10653-7
93. Isgro A, Marziali M, Mezzaroma I, et al. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol 2005;174(8): 5074-81
94. Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007;178(6): 3932-43
95. Guazzi V, Aiuti F, Mezzaroma I, et al. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol 2002;129(2):346-53
96. Pons J, Ferrer JM, Martinez-Pomar N, et al. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease. Scand J Immunol 2006;63(5):383-9
97. Denz A, Eibel H, Illges H, et al Impaired Up-regulation of CD86 in B Cells of "Type A" Common Variable Immunodeficiency Patients. Eur J Immunol 2000;30(4): 1069-77
98. Groth C, Drager R, Warnatz K, et al. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2002;129(1):133-9
99. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 2004;104(8):2441-3
100. Kaser A, Kaser S, Kaneider NC, et al. Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood 2004; 103(2):648-55
101. Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease. Blood 2002;99(5):1544-51
102. Alachkar H, Taubenheim N, Haeney MR, et al. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol 2006;120(3):310-18
103. Ming JE, Stiehm ER, Graham JM Jr. Syndromic immunodeficiencies: Genetic syndromes associated with immune abnormalities. Crit Rev Clin Lab Sci 2003; 40(6):587-642
104. Rezaei N, Farhoudi A, Pourpak Z, et al. Neutropenia in patients with primary antibody deficiency disorders. Iran J Allergy Asthma Immunol 2004;3(2):77-81
105. +T cell clones in human immunodeficiency virus infection. J Exp Med 1994;180(6):2407-11
106. Holm AM, Aukrust P, Damas JK, et al. Abnormal interleukin-7 function in common variable immunodeficiency. Blood 2005;105(7):2887-90
107. Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005;5(6):504-9
108. Abolhassani H, Wang N, Aghamohammadi A, et al. A hypomorphic recombination-Activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol 2014. [Epub ahead of print]
109. Abolhassani H, Cheraghi T, Reseal N, et al. Common variable immunodeficiency or late onset combined immunodeficiency: New hypomorphic JAK3 patient and a literature review. J Investig Allergol Clin Immunol 2015. [Epub ahead of print]
110. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-Alpha polymorphisms associated with common variable immunodeficiency: Role in the pathogenesis of granulomatous disease. J Immunol 1997;159(12):6236-41
111. Alper CA, Marcus-Bagley D, Awdeh Z, et al. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 2000; 56(3):207-16
112. Schroeder HW Jr, Zhu ZB, March RE, et al. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3,-B8,-A1 haplotypes. Molecular medicine 1998;4(2):72-86
113. De La Concha EG, Fernandez-Arquero M, Martinez A, et al. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol 1999;116(3):516-20
114. Holm AM, Aukrust P, Aandahl EM, et al. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency-involvement of protein kinase A type I. J Immunol 2003;170(11): 5772-7
115. Zhou Z, Huang R, Danon M, et al. IL-10 production in common variable immunodeficiency. Clin Immunol Immunopathol 1998;86(3):298-304
116. Mullighan CG, Marshall SE, Bunce M, Welsh KI. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun 1999;1(2):137-48
117. Offer SM, Pan-Hammarstrom Q, Hammarstrom L, Harris RS. Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID. PLoS One 2010;5(8):e12260
118. Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: A review. Clin Exp Med 2004;3(4):211-17
119. Litzman J, Freiberger T, Grimbacher B, et al. Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin Exp Immunol 2008;153(3):324-30
120. Mullighan CG, Marshall SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 2000; 51(2):111-22
121. Goldacker S, Draeger R, Warnatz K, et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol 2007;124(3):294-303
122. Ballow M. Intravenous immunoglobulins: Clinical experience and viral safety. J Am Pharm Assoc (Wash) 2002;42(3):449-58; quiz 458-449
123. Skull S, Kemp A. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93. Arch Dis Child 1996;74(6):527-30
124. Aghamohammadi A, Farhoudi A, Nikzad M, et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann Allergy Asthma Immunol 2004;92(1):60-4
125. Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, et al. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol 2009;19(2):139-45
126. de Gracia J, Vendrell M, Alvarez A, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004;4(6):745-53
127. Favre O, Leimgruber A, Nicole A, Spertini F. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency. Allergy 2005;60(3):385-90
128. Aghamohammadi A, Moazzami K, Rezaei N, et al. ENT manifestations in Iranian patients with primary antibody deficiencies. J Laryngol Otol 2008;122(4):409-13
129. Chapel H. Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. Clin Exp Immunol 2012;168(1):58-9
130. Chapel H, Geha R, Rosen F; committee IPC. Primary immunodeficiency diseases: An update. Clin Exp Immunol 2003;132(1): 9-15